To hear about similar clinical trials, please enter your email below
Trial Title:
The Effect of Premedication on Postoperative Pain and Anxiety in Breast Cancer Surgery
NCT ID:
NCT05647642
Condition:
Female Patients Under the Age of 65 Who Will Undergo Breast Cancer Surgery
Conditions: Official terms:
Breast Neoplasms
Midazolam
Dexmedetomidine
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Drug
Intervention name:
Precedex and dormicum
Description:
Premedication
Arm group label:
high dose dexmedetothymidine
Arm group label:
high dose midazolam
Arm group label:
low dose dexmedetothymidine
Arm group label:
low dose midazolam
Summary:
In this study, it was investigated whether the premedication drug administered before the
surgery had an effect on postoperative pain and anxiety scores in female patients under
the age of 65 who will undergo breast cancer surgery.
Detailed description:
In this study, it was investigated whether the premedication drug administered before the
surgery had an effect on postoperative pain and anxiety scores in female patients under
the age of 65 who will undergo breast cancer surgery. The STAI-1(State Trait Anxiety
İnventory ) form and APAIS (Amsterdam Preoperative Anxiety and İnformation Scale) scale
were filled in for all preoperative patients. Afterwards, the patients were treated with
either midazolam or dexmedetothymidine, depending on the anesthesiologist's preference.
After administration, he was taken to surgery. As intraoperative analgesics, 2 mg/kg
tramadol and 15 mg/kg paracetamol were administered to all patients. postoperative
recovery time (aldrete 10), 1., 2.,6.,12.,24. VAS score, postoperative nausea-vomiting
scale, STAI-1(State Trait Anxiety İnventory ) form, first need time if postoperative
analgesic was needed, and 24-hour total analgesic consumption were recorded. It was aimed
to examine the effects of different premedications on postoperative pain and anxiety
Criteria for eligibility:
Study pop:
ASA 1-2-3, female patients aged 18-65 who will undergo breast cancer surgery
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- ASA 1-2-3
- 18-65 aged
- Female patients
Exclusion Criteria:
- Under 18 years old and over 65 years old
- Having a history of cerebrovascular disease illiteracy
- Have visual and auditory problems İnability to cooperate with cognitive function
test
- Having emergency surgery
- Those who are unable to read, understand and sign the consent form
- Patients deemed unsuitable by the investigator
Gender:
Female
Minimum age:
18 Years
Maximum age:
65 Years
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
AbdurrahmanYAOTRH
Address:
City:
Ankara
Country:
Turkey
Status:
Recruiting
Contact:
Last name:
Abdurrahman Yurtaslan Onkoloji Training and Research Hospital
Start date:
October 16, 2022
Completion date:
January 30, 2023
Lead sponsor:
Agency:
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Agency class:
Other
Source:
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05647642
